|
gptkbp:instanceOf
|
gptkb:drug
fixed-dose combination medication
|
|
gptkbp:activeIngredient
|
gptkb:elvitegravir
gptkb:cobicistat
gptkb:tenofovir_alafenamide
emtricitabine
|
|
gptkbp:approvalYear
|
2015
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
J05AR17
|
|
gptkbp:contraindication
|
severe liver impairment
concurrent use with certain drugs (e.g., rifampin)
|
|
gptkbp:drugClass
|
antiretroviral therapy
nucleoside reverse transcriptase inhibitor combination
integrase inhibitor combination
pharmacokinetic enhancer combination
|
|
gptkbp:form
|
gptkb:tablet
film-coated tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Genvoya
|
|
gptkbp:indication
|
treatment of HIV-1 infection in adults and pediatric patients
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Gilead_Sciences
|
|
gptkbp:marketedIn
|
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescriptionStatus
|
Rx-only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
abdominal pain
fatigue
headache
|
|
gptkbp:storage
|
store below 30°C (86°F)
|
|
gptkbp:usedFor
|
HIV infection
|
|
gptkbp:website
|
https://www.genvoya.com/
|
|
gptkbp:bfsParent
|
gptkb:DB06151
gptkb:tenofovir_alafenamide
gptkb:DB04876
|
|
gptkbp:bfsLayer
|
7
|